請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/41969
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 張明富 | |
dc.contributor.author | Shun-Chi Wu | en |
dc.contributor.author | 吳舜祺 | zh_TW |
dc.date.accessioned | 2021-06-15T00:39:48Z | - |
dc.date.available | 2011-12-18 | |
dc.date.copyright | 2008-12-18 | |
dc.date.issued | 2008 | |
dc.date.submitted | 2008-10-14 | |
dc.identifier.citation | 1. Arima, N., C. Y. Kao, T. Licht, R. Padmanabhan, and Y. Sasaguri. 2001. Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A. J Biol Chem 276:12675-84.
2. Baek, K. H., H. Y. Park, C. M. Kang, S. J. Kim, S. J. Jeong, E. K. Hong, J. W. Park, Y. C. Sung, T. Suzuki, C. M. Kim, and C. W. Lee. 2006. Overexpression of hepatitis C virus NS5A protein induces chromosome instability via mitotic cell cycle dysregulation. J Mol Biol 359:22-34. 3. Bahler, M., and A. Rhoads. 2002. Calmodulin signaling via the IQ motif. FEBS Lett 513:107-13. 4. Bartenschlager, R., L. Ahlborn-Laake, J. Mous, and H. Jacobsen. 1994. Kinetic and structural analyses of hepatitis C virus polyprotein processing. J Virol 68:5045-55. 5. Behrens, S. E., L. Tomei, and R. De Francesco. 1996. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J 15:12-22. 6. Bond, J., E. Roberts, G. H. Mochida, D. J. Hampshire, S. Scott, J. M. Askham, K. Springell, M. Mahadevan, Y. J. Crow, A. F. Markham, C. A. Walsh, and C. G. Woods. 2002. ASPM is a major determinant of cerebral cortical size. Nat Genet 32:316-20. 7. Bond, J., E. Roberts, K. Springell, S. B. Lizarraga, S. Scott, J. Higgins, D. J. Hampshire, E. E. Morrison, G. F. Leal, E. O. Silva, S. M. Costa, D. Baralle, M. Raponi, G. Karbani, Y. Rashid, H. Jafri, C. Bennett, P. Corry, C. A. Walsh, and C. G. Woods. 2005. A centrosomal mechanism involving CDK5RAP2 and CENPJ controls brain size. Nat Genet 37:353-5. 8. Bradley, D. W. 1985. The agents of non-A, non-B viral hepatitis. J Virol Methods 10:307-19. 9. Brown, E. A., H. Zhang, L. H. Ping, and S. M. Lemon. 1992. Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res 20:5041-5. 10. Bukh, J., R. H. Purcell, and R. H. Miller. 1992. Sequence analysis of the 5' noncoding region of hepatitis C virus. Proc Natl Acad Sci U S A 89:4942-6. 11. Bukh, J., R. H. Purcell, and R. H. Miller. 1994. Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc Natl Acad Sci U S A 91:8239-43. 12. Cha, T. A., E. Beall, B. Irvine, J. Kolberg, D. Chien, G. Kuo, and M. S. Urdea. 1992. At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci U S A 89:7144-8. 13. Chang, S. C., J. H. Yen, H. Y. Kang, M. H. Jang, and M. F. Chang. 1994. Nuclear localization signals in the core protein of hepatitis C virus. Biochem Biophys Res Commun 205:1284-90. 14. Chen, C. M., L. R. You, L. H. Hwang, and Y. H. Lee. 1997. Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor. J Virol 71:9417-26. 15. Chen, H. F., C. Y. Li, P. Chen, T. T. See, and H. Y. Lee. 2006. Seroprevalence of hepatitis B and C in type 2 diabetic patients. J Chin Med Assoc 69:146-52. 16. Chen, P. J., M. H. Lin, K. F. Tai, P. C. Liu, C. J. Lin, and D. S. Chen. 1992. The Taiwanese hepatitis C virus genome: sequence determination and mapping the 5' termini of viral genomic and antigenomic RNA. Virology 188:102-13. 17. Choo, Q. L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-62. 18. Choo, Q. L., K. H. Richman, J. H. Han, K. Berger, C. Lee, C. Dong, C. Gallegos, D. Coit, R. Medina-Selby, P. J. Barr, and et al. 1991. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 88:2451-5. 19. Cuenda, A., and S. Rousseau. 2007. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 1773:1358-75. 20. Di Bisceglie, A. M., S. E. Order, J. L. Klein, J. G. Waggoner, M. H. Sjogren, G. Kuo, M. Houghton, Q. L. Choo, and J. H. Hoofnagle. 1991. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gastroenterol 86:335-8. 21. do Carmo Avides, M., and D. M. Glover. 1999. Abnormal spindle protein, Asp, and the integrity of mitotic centrosomal microtubule organizing centers. Science 283:1733-5. 22. do Carmo Avides, M., A. Tavares, and D. M. Glover. 2001. Polo kinase and Asp are needed to promote the mitotic organizing activity of centrosomes. Nat Cell Biol 3:421-4. 23. Eckart, M. R., M. Selby, F. Masiarz, C. Lee, K. Berger, K. Crawford, C. Kuo, G. Kuo, M. Houghton, and Q. L. Choo. 1993. The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor. Biochem Biophys Res Commun 192:399-406. 24. Enomoto, N., I. Sakuma, Y. Asahina, M. Kurosaki, T. Murakami, C. Yamamoto, Y. Ogura, N. Izumi, F. Marumo, and C. Sato. 1996. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 334:77-81. 25. Evans, P. D., J. R. Anderson, E. J. Vallender, S. L. Gilbert, C. M. Malcom, S. Dorus, and B. T. Lahn. 2004. Adaptive evolution of ASPM, a major determinant of cerebral cortical size in humans. Hum Mol Genet 13:489-94. 26. Failla, C., L. Tomei, and R. De Francesco. 1995. An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A. J Virol 69:1769-77. 27. Failla, C., L. Tomei, and R. De Francesco. 1994. Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins. J Virol 68:3753-60. 28. Fish, J. L., Y. Kosodo, W. Enard, S. Paabo, and W. B. Huttner. 2006. Aspm specifically maintains symmetric proliferative divisions of neuroepithelial cells. Proc Natl Acad Sci U S A 103:10438-43. 29. Gale, M., Jr., C. M. Blakely, B. Kwieciszewski, S. L. Tan, M. Dossett, N. M. Tang, M. J. Korth, S. J. Polyak, D. R. Gretch, and M. G. Katze. 1998. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 18:5208-18. 30. Ghosh, A. K., M. Majumder, R. Steele, K. Meyer, R. Ray, and R. B. Ray. 2000. Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death. Virus Res 67:173-8. 31. Ghosh, A. K., R. Steele, K. Meyer, R. Ray, and R. B. Ray. 1999. Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. J Gen Virol 80 ( Pt 5):1179-83. 32. Gimona, M., K. Djinovic-Carugo, W. J. Kranewitter, and S. J. Winder. 2002. Functional plasticity of CH domains. FEBS Lett 513:98-106. 33. Glover, D. M. 2005. Polo kinase and progression through M phase in Drosophila: a perspective from the spindle poles. Oncogene 24:230-7. 34. Grakoui, A., D. W. McCourt, C. Wychowski, S. M. Feinstone, and C. M. Rice. 1993. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol 67:2832-43. 35. Grakoui, A., D. W. McCourt, C. Wychowski, S. M. Feinstone, and C. M. Rice. 1993. A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci U S A 90:10583-7. 36. Gumber, S. C., and S. Chopra. 1995. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 123:615-20. 37. Han, J. H., V. Shyamala, K. H. Richman, M. J. Brauer, B. Irvine, M. S. Urdea, P. Tekamp-Olson, G. Kuo, Q. L. Choo, and M. Houghton. 1991. Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end. Proc Natl Acad Sci U S A 88:1711-5. 38. He, Y., H. Nakao, S. L. Tan, S. J. Polyak, P. Neddermann, S. Vijaysri, B. L. Jacobs, and M. G. Katze. 2002. Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase. J Virol 76:9207-17. 39. He, Y., S. L. Tan, S. U. Tareen, S. Vijaysri, J. O. Langland, B. L. Jacobs, and M. G. Katze. 2001. Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A. J Virol 75:5090-8. 40. Hijikata, M., N. Kato, Y. Ootsuyama, M. Nakagawa, S. Ohkoshi, and K. Shimotohno. 1991. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 175:220-8. 41. Hijikata, M., N. Kato, Y. Ootsuyama, M. Nakagawa, and K. Shimotohno. 1991. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci U S A 88:5547-51. 42. Hijikata, M., H. Mizushima, T. Akagi, S. Mori, N. Kakiuchi, N. Kato, T. Tanaka, K. Kimura, and K. Shimotohno. 1993. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol 67:4665-75. 43. Hijikata, M., H. Mizushima, Y. Tanji, Y. Komoda, Y. Hirowatari, T. Akagi, N. Kato, K. Kimura, and K. Shimotohno. 1993. Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci U S A 90:10773-7. 44. Hirota, M., S. Satoh, S. Asabe, M. Kohara, K. Tsukiyama-Kohara, N. Kato, M. Hijikata, and K. Shimotohno. 1999. Phosphorylation of nonstructural 5A protein of hepatitis C virus: HCV group-specific hyperphosphorylation. Virology 257:130-7. 45. Holland, J., K. Spindler, F. Horodyski, E. Grabau, S. Nichol, and S. VandePol. 1982. Rapid evolution of RNA genomes. Science 215:1577-85. 46. Honda, M., M. R. Beard, L. H. Ping, and S. M. Lemon. 1999. A phylogenetically conserved stem-loop structure at the 5' border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J Virol 73:1165-74. 47. Honda, M., L. H. Ping, R. C. Rijnbrand, E. Amphlett, B. Clarke, D. Rowlands, and S. M. Lemon. 1996. Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology 222:31-42. 48. Horvath, S., B. Zhang, M. Carlson, K. V. Lu, S. Zhu, R. M. Felciano, M. F. Laurance, W. Zhao, S. Qi, Z. Chen, Y. Lee, A. C. Scheck, L. M. Liau, H. Wu, D. H. Geschwind, P. G. Febbo, H. I. Kornblum, T. F. Cloughesy, S. F. Nelson, and P. S. Mischel. 2006. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A 103:17402-7. 49. Houdusse, A., M. Silver, and C. Cohen. 1996. A model of Ca(2+)-free calmodulin binding to unconventional myosins reveals how calmodulin acts as a regulatory switch. Structure 4:1475-90. 50. Ishida, S., M. Kaito, M. Kohara, K. Tsukiyama-Kohora, N. Fujita, J. Ikoma, Y. Adachi, and S. Watanabe. 2001. Hepatitis C virus core particle detected by immunoelectron microscopy and optical rotation technique. Hepatol Res 20:335-347. 51. Kaito, M., S. Watanabe, K. Tsukiyama-Kohara, K. Yamaguchi, Y. Kobayashi, M. Konishi, M. Yokoi, S. Ishida, S. Suzuki, and M. Kohara. 1994. Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol 75 ( Pt 7):1755-60. 52. Kaneko, T., Y. Tanji, S. Satoh, M. Hijikata, S. Asabe, K. Kimura, and K. Shimotohno. 1994. Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. Biochem Biophys Res Commun 205:320-6. 53. Kato, N., M. Hijikata, Y. Ootsuyama, M. Nakagawa, S. Ohkoshi, T. Sugimura, and K. Shimotohno. 1990. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A 87:9524-8. 54. Kato, N., H. Yoshida, S. K. Ono-Nita, J. Kato, T. Goto, M. Otsuka, K. Lan, K. Matsushima, Y. Shiratori, and M. Omata. 2000. Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer. Hepatology 32:405-12. 55. Koike, K. 2005. Hepatitis C as a metabolic disease: Implication for the pathogenesis of NASH. Hepatol Res 33:145-50. 56. Korenbaum, E., and F. Rivero. 2002. Calponin homology domains at a glance. J Cell Sci 115:3543-5. 57. Kouprina, N., A. Pavlicek, G. H. Mochida, G. Solomon, W. Gersch, Y. H. Yoon, R. Collura, M. Ruvolo, J. C. Barrett, C. G. Woods, C. A. Walsh, J. Jurka, and V. Larionov. 2004. Accelerated evolution of the ASPM gene controlling brain size begins prior to human brain expansion. PLoS Biol 2:E126. 58. Kuo, G., Q. L. Choo, H. J. Alter, G. L. Gitnick, A. G. Redeker, R. H. Purcell, T. Miyamura, J. L. Dienstag, M. J. Alter, C. E. Stevens, and et al. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-4. 59. Lai, C. F., L. Chaudhary, A. Fausto, L. R. Halstead, D. S. Ory, L. V. Avioli, and S. L. Cheng. 2001. Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 276:14443-50. 60. Lai, M. Y., J. H. Kao, P. M. Yang, J. T. Wang, P. J. Chen, K. W. Chan, J. S. Chu, and D. S. Chen. 1996. Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C. Gastroenterology 111:1307-12. 61. Lin, C., and C. M. Rice. 1995. The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay. Proc Natl Acad Sci U S A 92:7622-6. 62. Lin, S. Y., H. W. Pan, S. H. Liu, Y. M. Jeng, F. C. Hu, S. Y. Peng, P. L. Lai, and H. C. Hsu. 2008. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma. Clin Cancer Res 14:4814-20. 63. Liu, Q., C. Tackney, R. A. Bhat, A. M. Prince, and P. Zhang. 1997. Regulated processing of hepatitis C virus core protein is linked to subcellular localization. J Virol 71:657-62. 64. Lohmann, V., F. Korner, U. Herian, and R. Bartenschlager. 1997. Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. J Virol 71:8416-28. 65. Lonardo, A., L. E. Adinolfi, P. Loria, N. Carulli, G. Ruggiero, and C. P. Day. 2004. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology 126:586-97. 66. Luers, G. H., M. Michels, U. Schwaab, and T. Franz. 2002. Murine calmodulin binding protein 1 (Calmbp1): tissue-specific expression during development and in adult tissues. Mech Dev 118:229-32. 67. Majumder, M., A. K. Ghosh, R. Steele, R. Ray, and R. B. Ray. 2001. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol 75:1401-7. 68. Manabe, S., I. Fuke, O. Tanishita, C. Kaji, Y. Gomi, S. Yoshida, C. Mori, A. Takamizawa, I. Yosida, and H. Okayama. 1994. Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3. Virology 198:636-44. 69. Martell, M., J. I. Esteban, J. Quer, J. Genesca, A. Weiner, R. Esteban, J. Guardia, and J. Gomez. 1992. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 66:3225-9. 70. Martin, S. R., and P. M. Bayley. 2002. Regulatory implications of a novel mode of interaction of calmodulin with a double IQ-motif target sequence from murine dilute myosin V. Protein Sci 11:2909-23. 71. Matsumoto, M., T. Y. Hsieh, N. Zhu, T. VanArsdale, S. B. Hwang, K. S. Jeng, A. E. Gorbalenya, S. Y. Lo, J. H. Ou, C. F. Ware, and M. M. Lai. 1997. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol 71:1301-9. 72. McCreary, B. D., J. P. Rossiter, and D. M. Robertson. 1996. Recessive (true) microcephaly: a case report with neuropathological observations. J Intellect Disabil Res 40 ( Pt 1):66-70. 73. Mehta, S. H., F. L. Brancati, M. S. Sulkowski, S. A. Strathdee, M. Szklo, and D. L. Thomas. 2000. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 133:592-9. 74. Mizushima, H., M. Hijikata, Y. Tanji, K. Kimura, and K. Shimotohno. 1994. Analysis of N-terminal processing of hepatitis C virus nonstructural protein 2. J Virol 68:2731-4. 75. Mochida, G. H., and C. A. Walsh. 2001. Molecular genetics of human microcephaly. Curr Opin Neurol 14:151-6. 76. Mooseker, M. S., and R. E. Cheney. 1995. Unconventional myosins. Annu Rev Cell Dev Biol 11:633-75. 77. Moriya, K., H. Fujie, Y. Shintani, H. Yotsuyanagi, T. Tsutsumi, K. Ishibashi, Y. Matsuura, S. Kimura, T. Miyamura, and K. Koike. 1998. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4:1065-7. 78. Moriya, K., H. Yotsuyanagi, Y. Shintani, H. Fujie, K. Ishibashi, Y. Matsuura, T. Miyamura, and K. Koike. 1997. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 78 ( Pt 7):1527-31. 79. Ogata, N., H. J. Alter, R. H. Miller, and R. H. Purcell. 1991. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A 88:3392-6. 80. Park, J. S., J. M. Yang, and M. K. Min. 2000. Hepatitis C virus nonstructural protein NS4B transforms NIH3T3 cells in cooperation with the Ha-ras oncogene. Biochem Biophys Res Commun 267:581-7. 81. Park, K. J., S. H. Choi, D. H. Choi, J. M. Park, S. W. Yie, S. Y. Lee, and S. B. Hwang. 2003. 1Hepatitis C virus NS5A protein modulates c-Jun N-terminal kinase through interaction with tumor necrosis factor receptor-associated factor 2. J Biol Chem 278:30711-8. 82. Plagemann, P. G. 1991. Hepatitis C virus. Arch Virol 120:165-80. 83. Ravaggi, A., G. Natoli, D. Primi, A. Albertini, M. Levrero, and E. Cariani. 1994. Intracellular localization of full-length and truncated hepatitis C virus core protein expressed in mammalian cells. J Hepatol 20:833-6. 84. Ray, R. B., L. M. Lagging, K. Meyer, and R. Ray. 1996. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 70:4438-43. 85. Ray, R. B., K. Meyer, and R. Ray. 1996. Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 226:176-82. 86. Rennefahrt, U., B. Illert, A. Greiner, U. R. Rapp, and J. Troppmair. 2004. Tumor induction by activated JNK occurs through deregulation of cellular growth. Cancer Lett 215:113-24. 87. Rizzetto, M., M. G. Canese, J. L. Gerin, W. T. London, D. L. Sly, and R. H. Purcell. 1980. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis 141:590-602. 88. Roberts, E., D. J. Hampshire, L. Pattison, K. Springell, H. Jafri, P. Corry, J. Mannon, Y. Rashid, Y. Crow, J. Bond, and C. G. Woods. 2002. Autosomal recessive primary microcephaly: an analysis of locus heterogeneity and phenotypic variation. J Med Genet 39:718-21. 89. Ruggieri, A., T. Harada, Y. Matsuura, and T. Miyamura. 1997. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology 229:68-76. 90. Santolini, E., G. Migliaccio, and N. La Monica. 1994. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol 68:3631-41. 91. Saunders, R. D., M. C. Avides, T. Howard, C. Gonzalez, and D. M. Glover. 1997. The Drosophila gene abnormal spindle encodes a novel microtubule-associated protein that associates with the polar regions of the mitotic spindle. J Cell Biol 137:881-90. 92. Shepard, C. W., L. Finelli, and M. J. Alter. 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5:558-67. 93. Simmonds, P., A. Alberti, H. J. Alter, F. Bonino, D. W. Bradley, C. Brechot, J. T. Brouwer, S. W. Chan, K. Chayama, D. S. Chen, and et al. 1994. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19:1321-4. 94. Spaete, R. R., D. Alexander, M. E. Rugroden, Q. L. Choo, K. Berger, K. Crawford, C. Kuo, S. Leng, C. Lee, R. Ralston, and et al. 1992. Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells. Virology 188:819-30. 95. Street, A., A. Macdonald, K. Crowder, and M. Harris. 2004. The Hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade. J Biol Chem 279:12232-41. 96. Sy, T., and M. M. Jamal. 2006. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci 3:41-6. 97. Tai, C. L., W. K. Chi, D. S. Chen, and L. H. Hwang. 1996. The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3). J Virol 70:8477-84. 98. Takahashi, K., S. Kishimoto, H. Yoshizawa, H. Okamoto, A. Yoshikawa, and S. Mishiro. 1992. p26 protein and 33-nm particle associated with nucleocapsid of hepatitis C virus recovered from the circulation of infected hosts. Virology 191:431-4. 99. Takamizawa, A., C. Mori, I. Fuke, S. Manabe, S. Murakami, J. Fujita, E. Onishi, T. Andoh, I. Yoshida, and H. Okayama. 1991. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 65:1105-13. 100. Tan, S. L., H. Nakao, Y. He, S. Vijaysri, P. Neddermann, B. L. Jacobs, B. J. Mayer, and M. G. Katze. 1999. NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc Natl Acad Sci U S A 96:5533-8. 101. Tanaka, T., N. Kato, M. J. Cho, and K. Shimotohno. 1995. A novel sequence found at the 3' terminus of hepatitis C virus genome. Biochem Biophys Res Commun 215:744-9. 102. Tanji, Y., T. Kaneko, S. Satoh, and K. Shimotohno. 1995. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J Virol 69:3980-6. 103. Tsukiyama-Kohara, K., N. Iizuka, M. Kohara, and A. Nomoto. 1992. Internal ribosome entry site within hepatitis C virus RNA. J Virol 66:1476-83. 104. Tu, H., L. Gao, S. T. Shi, D. R. Taylor, T. Yang, A. K. Mircheff, Y. Wen, A. E. Gorbalenya, S. B. Hwang, and M. M. Lai. 1999. Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. Virology 263:30-41. 105. van Doorn, L. J., I. Capriles, G. Maertens, R. DeLeys, K. Murray, T. Kos, H. Schellekens, and W. Quint. 1995. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. J Virol 69:773-8. 106. Wasley, A., and M. J. Alter. 2000. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 20:1-16. 107. Weiner, A. J., M. J. Brauer, J. Rosenblatt, K. H. Richman, J. Tung, K. Crawford, F. Bonino, G. Saracco, Q. L. Choo, M. Houghton, and et al. 1991. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180:842-8. 108. Winder, S. J., and J. Kendrick-Jones. 1995. Calcium/calmodulin-dependent regulation of the NH2-terminal F-actin binding domain of utrophin. FEBS Lett 357:125-8. 109. Woods, C. G. 2004. Human microcephaly. Curr Opin Neurobiol 14:112-7. 110. Zhang, J. 2003. Evolution of the human ASPM gene, a major determinant of brain size. Genetics 165:2063-70. 111. Zhong, X., L. Liu, A. Zhao, G. P. Pfeifer, and X. Xu. 2005. The abnormal spindle-like, microcephaly-associated (ASPM) gene encodes a centrosomal protein. Cell Cycle 4:1227-9. 112. Zhu, N., A. Khoshnan, R. Schneider, M. Matsumoto, G. Dennert, C. Ware, and M. M. Lai. 1998. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 72:3691-7. 113. 廖珮茹. (2003). The effects of the NS5A protein of hepatitic C virus on cell growth.國立台灣大學醫學院微生物學研究所碩士論文 | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/41969 | - |
dc.description.abstract | C型肝炎病毒(HCV)感染後,大部分病人會演變成永久性帶原者並且可能引發肝癌發生。C型肝炎病毒非結構性蛋白質NS5A,目前已知會影響宿主細胞的生長和存活能力。最近的研究證明,NS5A蛋白質可能異常調控細胞週期中的有絲分裂階段,造成染色體不穩定,進而引發肝癌的發生。NS5A蛋白質已知會與宿主細胞中的PKR蛋白質形成異源雙體並抑制PKR蛋白質的活性,但NS5A對有絲分裂之影響仍不清楚。在本研究中,首先在老鼠系統以流體力學為基礎之體內轉染法進行實驗。成功表現出NS5A蛋白質的老鼠肝細胞,以雷射微切擷取方式分離出來,並且使用Affymetrix寡核苷酸微陣列系統,大規模地觀察有那些宿主細胞中基因的表現會被NS5A蛋白質所影響。結果發現,在34,000個基因中,有10個與細胞生長、發炎和細胞凋零相關的基因表現會被NS5A蛋白質所影響。其中一個受影響基因為Aspm (abnormal spindle-like, microcephaly associated)。反轉錄即時聚合酶連鎖反應及西方墨點法更進一步地確認在老鼠、C型肝炎病毒複製系統及細胞培養系統中,NS5A蛋白質均會負調控Aspm基因及ASPM蛋白質的表現。使用流式細胞儀分析,血清飢餓24小時再加入血清24小時,發現持續表現NS5A蛋白質之NIH3T3細胞,其細胞週期有較多比例停滯在G2/M階段。使用nocodazole處理24小時再將其移除48小時後,發現持續表現NS5A蛋白質之NIH3T3細胞,其細胞週期在sub-G1階段的比例,比控制組細胞明顯來得少,表示NS5A蛋白質具有抗細胞凋零的作用。另外,螢光素酶報導分析法證明NS5A蛋白質抑制Aspm基因啟動子的活性,但是將NS5A蛋白質之PKR結合區域重要的三個胺基酸突變,則失去此抑制效果。因為ASPM蛋白質為有絲分裂中紡錘體蛋白質,它可能是NS5A蛋白質在細胞週期調控中,一個嶄新的標靶基因。進一步使用MAPK和PKR的抑制劑,證明抑制Aspm基因的表現,表示NS5A蛋白質抑制Aspm基因是透過PKR-p38之訊息傳遞。而且,ASPM蛋白質的過度表現,能援救NS5A蛋白質所造成寄主細胞週期停滯在G2/M階段的表現型。實驗結果表明NS5A蛋白質抑制Aspm基因的表現,導致有絲分裂中紡錘體蛋白ASPM蛋白質的減少,使得有絲分裂異常,可能進而引起染色體不穩定和肝癌的發生。 | zh_TW |
dc.description.abstract | Hepatitis C virus (HCV) often causes a persistent infection and virus-associated hepatocellular carcinoma. The nonstructural protein NS5A of HCV is likely to be involved in the control of cell growth and viability. Recent studies demonstrated that HCV NS5A protein may be directly involved in the induction of chromosome instability via mitotic cell cycle dysregulation and provided insights into the molecular mechanisms of HCV-associated hepatocarcinogenesis. Although NS5A forms heterodimer with PKR and down-regulates the PKR activity, the effects of NS5A on mitosis are not clear. In this study, hydrodynamics-based in vivo transfection was applied to a mouse system. Mouse hepatocytes that successfully expressed NS5A protein were isolated by Laser Capture Microdissection and gene expression profiles were examined by Affymetrix oligonucleotide microarray system. Among 34,000 genes, 10 genes including Aspm (abnormal spindle-like, microcephaly associated) associated with cell growth, inflammation and apoptosis were differentially regulated. The down-regulation of Aspm mRNA and protein was confirmed by real-time reverse transcription-polymerase chain reaction and Western blot analysis both in the mouse model system and in the viral subgenomic replicon and in vitro transfection culture system. By flowcytometer analysis, cell cycle G2/M arrest was demonstrated in NIH3T3 cells constitutively expressing the NS5A. After release from nocodazole treatment, the sub-G1 population was significantly decreased in the synchronized NIH3T3 cells expressing NS5A as compared with that of parental NIH3T3 cells, indicating that the anti-apoptotic effect of NS5A. In addition, a luciferase reporter assay demonstrated that NS5A down-regulated the promoter activity of Aspm gene. The regulatory effect was reduced in the NS5A protein with mutation of PKR interaction domain. Because ASPM is a mitotic spindle protein, it maybe a novel target of NS5A in the cell cycle regulation. Further studies demonstrated that MAPK and PKR inhibitors down-regulated Aspm gene, indicating that NS5A down-regulates Aspm gene via the PKR-p38 signaling pathway. Moreover, overexpression of ASPM could rescue the phenotype of NS5A-inducing cell cycle G2/M arrest. Results suggest that the down-regulation of ASPM by HCV NS5A protein induces aberrant cell mitosis associated with chromosome instability and hepatocellular carcinoma. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T00:39:48Z (GMT). No. of bitstreams: 1 ntu-97-D90442007-1.pdf: 7638196 bytes, checksum: 6aeebedc18f32fa961757e64834b43d6 (MD5) Previous issue date: 2008 | en |
dc.description.tableofcontents | 中文摘要…………………………………………………………………I
英文摘要………………………………………………………………III 緒論………………………………………………………………………1 本論文研究方向………………………………………………………13 材料來源………………………………………………………………14 實驗方法………………………………………………………………20 結果……………………………………………………………………45 討論……………………………………………………………………55 圖表……………………………………………………………………59 參考文獻……………………………………………………………109 | |
dc.language.iso | zh-TW | |
dc.title | C型肝炎病毒非結構性蛋白質NS5A負調控PKR訊息傳遞下游路徑之分子機制 | zh_TW |
dc.title | Molecular Mechanisms of Hepatitis C Virus NS5A Protein Involved in the Down-Regulation of the Downstream PKR Signaling Pathway | en |
dc.type | Thesis | |
dc.date.schoolyear | 97-1 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 張玉生,林淑華,張智芬,楊性芳,廖經倫 | |
dc.subject.keyword | C型肝炎病毒,非結構性蛋白質,雷射微切擷取,微陣列,紡錘體蛋白, | zh_TW |
dc.subject.keyword | Hepatitis C virus,NS5A,Laser Capture Microdissection,microarray,ASPM, | en |
dc.relation.page | 118 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2008-10-14 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 生物化學暨分子生物學研究所 | zh_TW |
顯示於系所單位: | 生物化學暨分子生物學科研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-97-1.pdf 目前未授權公開取用 | 7.46 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。